Cargando…

Expression of Survivin in Oral Potentially Malignant Disorders: An Immunohistochemical Study

AIM: The aim of this study was to compare the immunohistochemical expression of survivin in oral potentially malignant disorders (OPMDs) and evaluate its prognostic significance among oral leukoplakia (OL), oral submucous fibrosis (OSMF), and oral lichen planus (OLP). MATERIALS AND METHODS: The stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajanna, Venkatraman R, Raveendranath, Murali C, Kathiresan, Shanmugam, Srinivasan, Soundarya, Ilango, Janani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595508/
https://www.ncbi.nlm.nih.gov/pubmed/33149491
http://dx.doi.org/10.4103/jpbs.JPBS_114_20
_version_ 1783601891440066560
author Rajanna, Venkatraman R
Raveendranath, Murali C
Kathiresan, Shanmugam
Srinivasan, Soundarya
Ilango, Janani
author_facet Rajanna, Venkatraman R
Raveendranath, Murali C
Kathiresan, Shanmugam
Srinivasan, Soundarya
Ilango, Janani
author_sort Rajanna, Venkatraman R
collection PubMed
description AIM: The aim of this study was to compare the immunohistochemical expression of survivin in oral potentially malignant disorders (OPMDs) and evaluate its prognostic significance among oral leukoplakia (OL), oral submucous fibrosis (OSMF), and oral lichen planus (OLP). MATERIALS AND METHODS: The study material consisted of 60 formalin-fixed paraffin-embedded tissue samples: 15 cases each of OL, OSMF, OLP, and normal oral mucosal epithelium as control. Survivin expression was analyzed immunohistochemically, and data analysis was accomplished using Statistical Package for Social Sciences, version 22.0 (SPSS Inc., Chicago, IL). Fisher’s chi-square test was opted to compare the study groups. RESULTS: Survivin was expressed in all the OPMDs including OL, OSMF, and OLP, but was absent in normal oral tissue samples. Higher immunoreactivity and survivin staining was observed in OLP compared to OL and OSMF whereas OL showed a significant difference in the distribution of survivin immunoexpression against OLP. An increased nuclear expression of survivin along with distribution in the basal and parabasal layers was evident in all OPMDs. CONCLUSION: Survivin was expressed more in OLP in comparison to OSMF and OLP, indicating unfavorable prognosis. OL showed increased expression in comparison to OSMF, showing unfavorable prognosis. On the basis of this study, it was concluded that survivin may be used as an important diagnostic and prognostic marker for OPMDs.
format Online
Article
Text
id pubmed-7595508
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-75955082020-11-03 Expression of Survivin in Oral Potentially Malignant Disorders: An Immunohistochemical Study Rajanna, Venkatraman R Raveendranath, Murali C Kathiresan, Shanmugam Srinivasan, Soundarya Ilango, Janani J Pharm Bioallied Sci Original Article AIM: The aim of this study was to compare the immunohistochemical expression of survivin in oral potentially malignant disorders (OPMDs) and evaluate its prognostic significance among oral leukoplakia (OL), oral submucous fibrosis (OSMF), and oral lichen planus (OLP). MATERIALS AND METHODS: The study material consisted of 60 formalin-fixed paraffin-embedded tissue samples: 15 cases each of OL, OSMF, OLP, and normal oral mucosal epithelium as control. Survivin expression was analyzed immunohistochemically, and data analysis was accomplished using Statistical Package for Social Sciences, version 22.0 (SPSS Inc., Chicago, IL). Fisher’s chi-square test was opted to compare the study groups. RESULTS: Survivin was expressed in all the OPMDs including OL, OSMF, and OLP, but was absent in normal oral tissue samples. Higher immunoreactivity and survivin staining was observed in OLP compared to OL and OSMF whereas OL showed a significant difference in the distribution of survivin immunoexpression against OLP. An increased nuclear expression of survivin along with distribution in the basal and parabasal layers was evident in all OPMDs. CONCLUSION: Survivin was expressed more in OLP in comparison to OSMF and OLP, indicating unfavorable prognosis. OL showed increased expression in comparison to OSMF, showing unfavorable prognosis. On the basis of this study, it was concluded that survivin may be used as an important diagnostic and prognostic marker for OPMDs. Wolters Kluwer - Medknow 2020-08 2020-08-28 /pmc/articles/PMC7595508/ /pubmed/33149491 http://dx.doi.org/10.4103/jpbs.JPBS_114_20 Text en Copyright: © 2020 Journal of Pharmacy and Bioallied Sciences http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Rajanna, Venkatraman R
Raveendranath, Murali C
Kathiresan, Shanmugam
Srinivasan, Soundarya
Ilango, Janani
Expression of Survivin in Oral Potentially Malignant Disorders: An Immunohistochemical Study
title Expression of Survivin in Oral Potentially Malignant Disorders: An Immunohistochemical Study
title_full Expression of Survivin in Oral Potentially Malignant Disorders: An Immunohistochemical Study
title_fullStr Expression of Survivin in Oral Potentially Malignant Disorders: An Immunohistochemical Study
title_full_unstemmed Expression of Survivin in Oral Potentially Malignant Disorders: An Immunohistochemical Study
title_short Expression of Survivin in Oral Potentially Malignant Disorders: An Immunohistochemical Study
title_sort expression of survivin in oral potentially malignant disorders: an immunohistochemical study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595508/
https://www.ncbi.nlm.nih.gov/pubmed/33149491
http://dx.doi.org/10.4103/jpbs.JPBS_114_20
work_keys_str_mv AT rajannavenkatramanr expressionofsurvivininoralpotentiallymalignantdisordersanimmunohistochemicalstudy
AT raveendranathmuralic expressionofsurvivininoralpotentiallymalignantdisordersanimmunohistochemicalstudy
AT kathiresanshanmugam expressionofsurvivininoralpotentiallymalignantdisordersanimmunohistochemicalstudy
AT srinivasansoundarya expressionofsurvivininoralpotentiallymalignantdisordersanimmunohistochemicalstudy
AT ilangojanani expressionofsurvivininoralpotentiallymalignantdisordersanimmunohistochemicalstudy